Developmental programming of eNOS uncoupling and enhanced vascular oxidative stress in adult rats after transient neonatal oxygen exposure

Journal of Cardiovascular Pharmacology

Volumn 61, Issue 1, 2013, Pages 8-16

  Yzydorczyk, Catherine ^a,b   Comte, Blandine ^b   Huyard, Fanny ^a   Cloutier, Anik ^a   Germain, Nathalie ^a   Bertagnolli, Mariane ^a   Nuyt, Anne Monique ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

Author keywords

developmental programming; endothelial nitric oxide synthase; oxygen; premature newborn; reactive oxygen species; superoxide anions; vascular dysfunction

Indexed keywords

4,5 DIAMINOFLUORESCEIN DIACETATE; ARGININE; ARGININE METHYL ESTER; CARBACHOL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYDROETHIDINE; OXYGEN; SEPIAPTERIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; FLUORESCENCE; HYPEROXIA; HYPERTENSION; IMMUNOHISTOCHEMISTRY; MALE; NEONATAL STRESS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; VASCULAR DISEASE; VASODILATATION;

AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; AORTA; ARGININE; CARBACHOL; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; HYPEROXIA; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; PTERINS; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDES; VASODILATION; VASODILATOR AGENTS;

EID: 84872298811     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0b013e318274d1c4     Document Type: Article

References (58)

1. Osmond C, Barker DJ. Fetal, infant, and childhood growth are predictors of coronary heart disease, diabetes, and hypertension in adult men and women. Environ Health Perspect. 2000;108(suppl 3):545-553.
2. Vohr BR, Allan W, Katz KH, et al. Early predictors of hypertension in prematurely born adolescents. Acta Paediatr. 2010;99:1812-1818.
3. Martin H, Hu J, Gennser G, et al. Impaired endothelial function and increased carotid stiffness in 9-year-old children with low birthweight. Circulation. 2000;102:2739-2744.
4. Skilton MR, Viikari JS, Juonala M, et al. Fetal growth and preterm birth influence cardiovascular risk factors and arterial health in young adults: the Cardiovascular Risk in Young Finns Study. Arterioscler Thromb Vasc Biol. 2011;31:2975-2981.
5. Cambonie G, Comte B, Yzydorczyk C, et al. Antenatal antioxidant prevents adult hypertension, vascular dysfunction, and microvascular rarefaction associated with in utero exposure to a low-protein diet. Am J Physiol Regul Integr Comp Physiol. 2007;292:R1236-R1245.
6. Racasan S, Braam B, van der Giezen DM, et al. Perinatal L-arginine and antioxidant supplements reduce adult blood pressure in spontaneously hypertensive rats. Hypertension. 2004;44:83-88.
7. Luo ZC, Fraser WD, Julien P, et al. Tracing the origins of "fetal origins" of adult diseases: programming by oxidative stress? Med Hypotheses. 2006;66:38-44.
8. Giussani DA, Camm EJ, Niu Y, et al. Developmental programming of cardiovascular dysfunction by prenatal hypoxia and oxidative stress. PLoS One. 2012;7:e31017.
9. Thompson LP, Al-Hasan Y. Impact of oxidative stress in fetal programming. J Pregnancy. 2012;2012:582748.
10. Comporti M, Signorini C, Leoncini S, et al. Plasma F2-isoprostanes are elevated in newborns and inversely correlated to gestational age. Free Radic Biol Med. 2004;37:724-732.
11. House JT, Schultetus RR, Gravenstein N. Continuous neonatal evaluation in the delivery room by pulse oximetry. J Clin Monit. 1987;3: 96-100.
12. Saik LA, Hsieh HL, Baricos WH, et al. Enzymatic and immunologic quantitation of erythrocyte superoxide dismutase in adults and in neonates of different gestational ages. Pediatr Res. 1982;16:933-937.
13. Georgeson GD, Szony BJ, Streitman K, et al. Antioxidant enzyme activities are decreased in preterm infants and in neonates born via caesarean section. Eur J Obstet Gynecol Reprod Biol. 2002;103:136-139.
14. Saugstad OD. Oxidative stress in the newborn-a 30-year perspective. Biol Neonate. 2005;88:228-236.
15. Ledo A, Arduini A, Asensi MA, et al. Human milk enhances antioxidant defenses against hydroxyl radical aggression in preterm infants. Am J Clin Nutr. 2009;89:210-215.
16. Asikainen TM, White CW. Pulmonary antioxidant defenses in the preterm newborn with respiratory distress and bronchopulmonary dysplasia in evolution: implications for antioxidant therapy. Antioxid Redox Signal. 2004;6:155-167.
17. Vento M, Moro M, Escrig R, et al. Preterm resuscitation with low oxygen causes less oxidative stress, inflammation, and chronic lung disease. Pediatrics. 2009;124:e439-e449.
18. Vina J, Vento M, Garcia-Sala F, et al. L-Cysteine and glutathione metabolism are impaired in premature infants due to cystathionase deficiency. Am J Clin Nutr. 1995;61:1067-1069.
19. Thebaud B, Ladha F, Michelakis ED, et al. Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxia-induced lung injury: evidence that angiogenesis participates in alveolarization. Circulation. 2005;112: 2477-2486.
20. Sapieha P, Joyal JS, Rivera JC, et al. Retinopathy of prematurity: understanding ischemic retinal vasculopathies at an extreme of life. J Clin Invest. 2010;120:3022-3032.
21. Yzydorczyk C, Comte B, Cambonie G, et al. Neonatal oxygen exposure in rats leads to cardiovascular and renal alterations in adulthood. Hypertension. 2008;52:889-895.
22. Forstermann U, Munzel T. Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation. 2006;113:1708-1714.
23. Kojima H, Nakatsubo N, Kikuchi K, et al. Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins. Anal Chem. 1998;70:2446-2453.
24. Franco MC, Ponzio BF, Gomes GN, et al. Micronutrient prenatal supplementation prevents the development of hypertension and vascular endothelial damage induced by intrauterine malnutrition. Life Sci. 2009;85:327-333.
25. Yzydorczyk C, Gobeil F Jr, Cambonie G, et al. Exaggerated vasomotor response to ANG II in rats with fetal programming of hypertension associated with exposure to a low-protein diet during gestation. Am J Physiol Regul Integr Comp Physiol. 2006;291:R1060-R1068.
26. Marchesi C, Ebrahimian T, Angulo O, et al. Endothelial nitric oxide synthase uncoupling and perivascular adipose oxidative stress and inflammation contribute to vascular dysfunction in a rodent model of metabolic syndrome. Hypertension. 2009;54:1384-1392.
27. Vasquez-Vivar J, Kalyanaraman B, Martasek P, et al. Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc Natl Acad Sci USA. 1998;95:9220-9225.
28. Bendall JK, Alp NJ, Warrick N, et al. Stoichiometric relationships between endothelial tetrahydrobiopterin, endothelial NO synthase (eNOS) activity, and eNOS coupling in vivo: insights from transgenic mice with endothelial-targeted GTP cyclohydrolase 1 and eNOS overexpression. Circ Res. 2005;97:864-871.
29. Franco MC, Fortes ZB, Akamine EH, et al. Tetrahydrobiopterin improves endothelial dysfunction and vascular oxidative stress in microvessels of intrauterine undernourished rats. J Physiol. 2004;558(pt 1): 239-248.
30. Yang YM, Huang A, Kaley G, et al. eNOS uncoupling and endothelial dysfunction in aged vessels. Am J Physiol Heart Circ Physiol. 2009;297: H1829-H1836.
31. Landmesser U, Dikalov S, Price SR, et al. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest. 2003;111:1201-1209.
32. Chalupsky K, Cai H. Endothelial dihydrofolate reductase: critical for nitric oxide bioavailability and role in angiotensin II uncoupling of endothelial nitric oxide synthase. Proc Natl Acad Sci USA. 2005;102: 9056-9061.
33. Crabtree MJ, Channon KM. Synthesis and recycling of tetrahydrobiopterin in endothelial function and vascular disease. Nitric Oxide. 2011.
34. Oak JH, Cai H. Attenuation of angiotensin II signaling recouples eNOS and inhibits nonendothelial NOX activity in diabetic mice. Diabetes. 2007;56:118-126.
35. Vasquez-Vivar J, Duquaine D, Whitsett J, et al. Altered tetrahydrobiopterin metabolism in atherosclerosis: implications for use of oxidized tetrahydrobiopterin analogues and thiol antioxidants. Arterioscler Thromb Vasc Biol. 2002;22:1655-1661.
36. Sydow K, Munzel T. ADMA and oxidative stress. Atheroscler Suppl. 2003;4:41-51.
37. Vida G, Sulyok E, Lakatos O, et al. Plasma levels of asymmetric dimethylarginine in premature neonates: its possible involvement in developmental programming of chronic diseases. Acta Paediatr. 2009;98:437-441.
38. Hellermann GR, Solomonson LP. Calmodulin promotes dimerization of the oxygenase domain of human endothelial nitric-oxide synthase. J Biol Chem. 1997;272:12030-12034.
39. Stuehr D, Pou S, Rosen GM. Oxygen reduction by nitric-oxide synthases. J Biol Chem. 2001;276:14533-14536.
40. Feron O, Dessy C, Opel DJ, et al. Modulation of the endothelial nitric-oxide synthase-caveolin interaction in cardiac myocytes. Implications for the autonomic regulation of heart rate. J Biol Chem. 1998;273:30249-30254.
41. Komers R, Schutzer WE, Reed JF, et al. Altered endothelial nitric oxide synthase targeting and conformation and caveolin-1 expression in the diabetic kidney. Diabetes. 2006;55:1651-1659.
42. Dudzinski DM, Michel T. Life history of eNOS: partners and pathways. Cardiovasc Res. 2007;75:247-260.
43. Sullivan JC, Pollock JS. NOS 3 subcellular localization in the regulation of nitric oxide production. Acta Physiol Scand. 2003;179:115-122.
44. Vaziri ND, Ni Z, Oveisi F. Upregulation of renal and vascular nitric oxide synthase in young spontaneously hypertensive rats. Hypertension. 1998;31:1248-1254.
45. Satoh M, Haruna Y, Fujimoto S, et al. Telmisartan improves endothelial dysfunction and renal autoregulation in Dahl salt-sensitive rats. Hypertens Res. 2010;33:135-142.
46. Franco MC, Arruda RM, Dantas AP, et al. Intrauterine undernutrition: expression and activity of the endothelial nitric oxide synthase in male and female adult offspring. Cardiovasc Res. 2002;56:145-153.
47. Oemar BS, Tschudi MR, Godoy N, et al. Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis. Circulation. 1998;97:2494-2498.
48. Kibbe M, Billiar T, Tzeng E. Inducible nitric oxide synthase and vascular injury. Cardiovasc Res. 1999;43:650-657.
49. Fleming I. Brain in the brawn: the neuronal nitric oxide synthase as a regulator of myogenic tone. Circ Res. 2003;93:586-588.
50. Kurihara N, Alfie ME, Sigmon DH, et al. Role of nNOS in blood pressure regulation in eNOS null mutant mice. Hypertension. 1998;32:856-861.
51. Jacobson A, Yan C, Gao Q, et al. Aging enhances pressure-induced arterial superoxide formation. Am J Physiol Heart Circ Physiol. 2007; 293:H1344-H1350.
52. Hink U, Li H, Mollnau H, et al. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res. 2001;88:E14-E22.
53. Laursen JB, Somers M, Kurz S, et al. Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin. Circulation. 2001;103:1282-1288.
54. Peterson TE, Poppa V, Ueba H, et al. Opposing effects of reactive oxygen species and cholesterol on endothelial nitric oxide synthase and endothelial cell caveolae. Circ Res. 1999;85:29-37.
55. Mivelaz Y, Yzydorczyk C, Barbier A, et al. Neonatal oxygen exposure leads to increased aortic wall stiffness in adult rats: a Doppler ultrasound study. J Dev Origins Health Dis. 2011;2:184-189.
56. Belik J, Jerkic M, McIntyre BA, et al. Age-dependent endothelial nitric oxide synthase uncoupling in pulmonary arteries of endoglin heterozygous mice. Am J Physiol Lung Cell Mol Physiol. 2009;297: L1170-L1178.
57. Kim JH, Bugaj LJ, Oh YJ, et al. Arginase inhibition restores NOS coupling and reverses endothelial dysfunction and vascular stiffness in old rats. J Appl Physiol. 2009;107:1249-1257.
58. Smith AR, Visioli F, Hagen TM. Plasma membrane-associated endothelial nitric oxide synthase and activity in aging rat aortic vascular endothelia markedly decline with age. Arch Biochem Biophys. 2006;454:100-105.